Neuropsychiatric Issues in Parkinson's Disease

被引:51
|
作者
Cooney, Jeffrey W. [1 ]
Stacy, Mark [2 ]
机构
[1] Duke Univ, Sch Med, 932 Morreene Rd, Durham, NC 27705 USA
[2] Duke Univ, Sch Med, 120a Davison, Durham, NC 27705 USA
关键词
Parkinson's disease; Non-motor symptoms; Depression; Cognitive impairment; Psychosis; Impulse control disorders; IMPULSE CONTROL DISORDERS; DOPAMINE DYSREGULATION SYNDROME; DRUG-INDUCED PSYCHOSIS; DEEP BRAIN-STIMULATION; RANDOMIZED CONTROLLED-TRIAL; AGONIST WITHDRAWAL SYNDROME; MILD COGNITIVE IMPAIRMENT; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; VISUAL HALLUCINATIONS;
D O I
10.1007/s11910-016-0647-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cognitive and neuropsychiatric symptoms are common in Parkinson's Disease and may surpass motor symptoms as the major factors impacting patient quality of life. The symptoms may be broadly separated into those associated with the disease process and those that represent adverse effects of treatment. Symptoms attributed to the disease arise from pathologic changes within multiple brain regions and are not restricted to dysfunction in the dopaminergic system. Mood symptoms such as depression, anxiety, and apathy are common and may precede the development of motor symptoms by years, while other neuropsychiatric symptoms such as cognitive impairment, dementia, and psychosis are more common in later stages of the disease. Neuropsychiatric symptoms attributed to treatment include impulse control disorders, pathologic use of dopaminergic medications, and psychosis. This manuscript will review the current understanding of neuropsychiatric symptoms in Parkinson's Disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease
    Martinez-Martin, Pablo
    Rodriguez-Blazquez, Carmen
    Forjaz, Maria Joao
    Frades-Payo, Belen
    Agueera-Ortiz, Luis
    Weintraub, Daniel
    Riesco, Ana
    Kurtis, Monica M.
    Chaudhuri, Kallol Ray
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (06) : 629 - 634
  • [42] Profiling cognitive and neuropsychiatric heterogeneity in Parkinson's disease
    van Balkom, Tim D.
    Vriend, Chris
    Berendse, Henk W.
    Foncke, Elisabeth M. J.
    van der Werf, Ysbrand D.
    van den Heuvel, Odile A.
    Klein, Martin
    PARKINSONISM & RELATED DISORDERS, 2016, 28 : 130 - 136
  • [43] Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease
    Mueller, Christoph
    Rajkumar, Anto P.
    Wan, Yi Min
    Velayudhan, Latha
    ffytche, Dominic
    Chaudhuri, Kallol Ray
    Aarsland, Dag
    CNS DRUGS, 2018, 32 (07) : 621 - 635
  • [44] Assessment and Management of Neuropsychiatric Symptoms in Parkinson’s Disease
    Christoph Mueller
    Anto P. Rajkumar
    Yi Min Wan
    Latha Velayudhan
    Dominic ffytche
    Kallol Ray Chaudhuri
    Dag Aarsland
    CNS Drugs, 2018, 32 : 621 - 635
  • [45] Defining neuropsychiatric symptoms fluctuations in Parkinson's disease
    Trinchillo, A.
    Cucinotta, F. P.
    De Angelis, A.
    Cociasu, I.
    Horne, M.
    Morgante, F.
    Ricciardi, L.
    MOVEMENT DISORDERS, 2023, 38 : S225 - S225
  • [46] Parkinson's disease - Part 3: Neuropsychiatric symptoms
    Weintraub, Daniel
    Comella, Cynthia L.
    Horn, Stacy
    AMERICAN JOURNAL OF MANAGED CARE, 2008, 14 (02): : S59 - S69
  • [47] Neuropsychiatric Treatments for Parkinson's Disease: Nonpharmacological Approaches
    Mathur, Neha
    Bhatt, Haseel
    Lidstone, Sarah C.
    SEMINARS IN NEUROLOGY, 2022, 42 (02) : 158 - 167
  • [48] Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease
    Bickel, Scott
    Alvarez, Lazaro
    Macias, Raul
    Pavon, Nancy
    Leon, Miraida
    Fernandez, Cristina
    Houghton, David J.
    Salazar, Sonia
    Rodriguez-Oroz, Maria C.
    Juncos, Jorge
    Guridi, Jorge
    DeLong, Mahlon
    Obeso, Jose A.
    Litvan, Irene
    PARKINSONISM & RELATED DISORDERS, 2010, 16 (08) : 535 - 539
  • [49] Drug treatments for the neuropsychiatric complications of Parkinson's disease
    Connolly, Barbara S.
    Fox, Susan H.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (12) : 1439 - 1449
  • [50] THE GENETIC BASIS OF NEUROPSYCHIATRIC SYMPTOMS IN PARKINSON'S DISEASE
    Moore, K.
    Johnston, J. A.
    O'Neill, F. A.
    Passmore, A. P.
    Ross, O. A.
    Lynch, T.
    Mulcahy, R.
    Craig, D.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : 60 - 60